Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic
Resource updated 06/09/2022
Resource updated 06/09/2022
Resource updated 12/21/2023
Resource updated 04/07/2023
Resource updated 09/19/2023
Resource (Conference Presentation) updated 09/14/2023
Resource updated 09/14/2023
Resource updated 02/28/2023
Resource updated 01/08/2024
Resource updated 03/04/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource updated 05/15/2024
Resource updated 09/19/2023
Resource updated 10/13/2023
Resource (Conference Presentation) updated 09/14/2023
Resource updated 03/04/2024
Description of how a modified Directly Observed Therapy (mDOT) program increased uptake of DOPT and the priority populations that experienced the uptake.
Resource (Conference Presentation) updated 09/14/2023
This HIV clinic evaluated effectiveness of telemedicine for selected patients during the first year of the COVID-19 pandemic, and found overall viral suppression and retention in care rates were not adversely impacted by switch to telemedicine. They also noted similar rates of telemedicine utilization across demographic criteria.
Resource (Conference Presentation) updated 09/14/2023